Michaelf Oshea News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michaelf oshea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michaelf Oshea Today - Breaking & Trending Today
Form 1-SA Xcelerate, Inc. For: Jun 30 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share this article MAULDIN, S.C., May 6, 2021 /PRNewswire/ Xcelerate, Inc. (OTC pink sheets: XCRT) today announced it has signed a non-binding letter of intent to pursue a business combination with HS Pharmaceuticals, LLC of Greenville, SC. Over the past 14 years HS Pharmaceuticals has developed a platform of novel technologies centered around their patented and patent pending silicate particle research. Their research, in conjunction with leading universities and research facilities, has led to developments in healthcare in areas such as immunotherapy alternatives, topical therapies to combat infection and bacteria as well bone regeneration. For more information visit their website www.hspharma.com. ....
MAULDIN, S.C., May 6, 2021 /PRNewswire/ Xcelerate, Inc. (OTC pink sheets: XCRT) today announced it has signed a non-binding letter of intent to pursue a business combination with HS Pharmaceuticals, LLC of Greenville, SC. Over the past 14 years HS Pharmaceuticals has developed a platform of novel technologies centered around their patented and patent pending silicate particle research. Their research, in conjunction with leading universities and research facilities, has led to developments in healthcare in areas such as immunotherapy alternatives, topical therapies to combat infection and bacteria as well bone regeneration. For more information visit their website www.hspharma.com. The LOI provides for XCRT to undertake its due diligence wherein its world-renowned team of clinicians and researchers will review HS Pharmaceuticals operations, structure, and intellectual property. During this process, Xcelerate, a rapidly emerging leader in assembling and deve ....